In Vitro Diagnostic Reagents Market to be Worth $75.67 Billion by 2030

In Vitro Diagnostic Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User – Global Forecast to 2030

The In Vitro Diagnostic Reagents Market is projected to reach $75.67 billion by 2030, at a CAGR of 5.4% from 2023 to 2030. IVD reagents are utilized in laboratory tests to identify the absence or presence of a certain condition in biological samples such as urine, blood, and other bodily fluids. IVD reagents include antibodies, oligonucleotides, nucleic acid probes, and other biomolecules specifically developed to interact with a specific biomarker or target molecule linked to a condition or disease. IVD reagents are used in various diagnostic procedures, including immunoassay/immunochemistry, molecular diagnostics, microbiology tests, and others, to diagnose infectious and chronic disorders.

The growth of this market is driven by the increasing prevalence of infectious diseases, increasing funding for research activities, the rising adoption of advanced diagnostic technologies, the growth in proteomics and genomics research studies, and the growing number of clinical laboratories offering advanced diagnostic testing menus. Additionally, emerging economies and the growing demand for protein therapeutics and personalized medicines are expected to offer significant market growth opportunities.